Metallothionein induction protects swollen rat primary astrocyte cultures from methylmercury-induced inhibition of...

Area of Science:

• Neuroscience
• Toxicology
• Cell Biology

Background:

• Metallothionein (MT) proteins are implicated in heavy metal detoxification.
• Methylmercury (MeHg) accumulates in astrocytes, which express MT-1 and MT-2 isoforms.
• Astrocytes are crucial for central nervous system function and vulnerable to toxins.

Purpose of the Study:

• To investigate the protective role of astrocyte-specific metallothioneins (MTs) against methylmercury (MeHg)-induced cytotoxicity.
• To determine if MT induction can attenuate the toxic effects of MeHg on astrocyte regulatory volume decrease (RVD).

Main Methods:

• Astrocytes were exposed to cadmium chloride (CdCl2) to induce MT expression.
• Cells were then subjected to hypotonic buffer and MeHg exposure to assess RVD and taurine release.
• Intracellular MT levels were correlated with the ability to volume regulate and taurine release.

Main Results:

• CdCl2 preexposure increased intracellular astrocyte MT levels in a time-dependent manner.
• MeHg-induced inhibition of RVD and taurine release was significantly reversed by CdCl2 preexposure.
• Astrocyte volume regulation in the presence of MeHg strongly correlated with intracellular MT levels (r = 0.99).

Conclusions:

• Astrocytes engineered to express high levels of MT proteins demonstrate resistance to the acute inhibitory effects of MeHg on RVD.
• MTs play a significant role in protecting astrocytes from MeHg-induced cytotoxicity.
• This suggests a potential therapeutic strategy for MeHg poisoning involving MT induction.